Genomic Deletions in Familial Melanoma
Author Information
Author(s): Lesueur F, de Lichy M, Barrois M, Durand G, Bombled J, Avril M-F, Chompret A, Boitier F, Lenoir G M, Bressac-de Paillerets B
Primary Institution: Institut Gustave Roussy, Villejuif, France
Hypothesis
What is the contribution of large genomic deletions at the CDKN2A locus to familial melanoma?
Conclusion
Large genomic deletions at the CDKN2A locus explain a very small proportion of cutaneous malignant melanoma susceptibility in familial cases.
Supporting Evidence
- About 20% of melanoma-prone families have a point mutation in the CDKN2A locus.
- Only 2.1% of total mutations in the study were large genomic deletions.
- One patient was identified with a novel deletion of CDKN2A exon 2.
Takeaway
This study looked at families with melanoma to see if big changes in their genes could explain why they get the disease. They found that these big changes are very rare.
Methodology
The study used multiplex ligation-dependent probe amplification to assess large genomic deletions in the CDKN2A locus among melanoma-prone families.
Limitations
The study did not cover the entire genomic sequence of CDKN2A, and other types of genomic alterations may not have been detected.
Participant Demographics
214 patients from independent pedigrees with at least two cases of cutaneous malignant melanoma.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website